Multiparametric Magnetic Resonance Imaging in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls and Correlations With Markers of Renal Function, Fibrosis, and Aging (MPRENAL): Protocol for a Longitudinal Observational Study.
9 affiliations
- 1Department of Nephrology, Aalborg University Hospital, Mølleparkvej 4, Aalborg, Denmark, +45 97663700.
- 2The MR Research Centre, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- 3Department of Radiology, Aalborg University Hospital, Aalborg, Denmark.
- 4Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
- 5Department of Internal Medicine, Aalborg University Hospital, Hobro, Denmark.
- 6Department of Pathology, Aarhus University Hospital, Aarhus, Denmark.
- 7Core Center for Molecular Morphology, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- 8Department of Renal Medicine, Aarhus University Hospital, Aarhus, Denmark.
- 9Department of Nuclear Medicine, Aalborg University Hospital, Aalborg, Denmark.
Abstract
Background
Renal fibrosis is the final common pathway of chronic kidney disease progression and a critical histological predictor of renal function decline and allograft failure. Routine clinical monitoring with estimated glomerular filtration rate (eGFR) and albuminuria is insensitive to fibrosis development. Renal biopsy is invasive and subject to sampling bias, which limits repeated assessment, thus necessitating noninvasive imaging biomarkers. Multiparametric magnetic resonance imaging (mpMRI) characterizes renal structure and function noninvasively. Individual MRI measures have been associated with fibrosis and with declining renal function. However, longitudinal validation against histology and measured glomerular filtration rate (mGFR) remains limited.Objective
This prospective longitudinal observational study aims to validate mpMRI against histological fibrosis assessed by kidney biopsy in kidney transplant recipients (KTRs), and compare the time-dependent trajectories of imaging and functional markers across living kidney donors (LKDs), KTRs, and healthy control (HC) cohorts.Methods
The planned sample includes 32 LKDs, 32 KTRs, and 32 HCs. Up to 40 KTRs may be recruited to account for attrition. Baseline assessments are performed before transplantation for LKDs and KTRs, and at enrollment for HCs, with follow-up assessments at 3, 12, and 24 months. mpMRI is performed at 3 tesla (3 T). The MRI protocol includes structural longitudinal relaxation time (T1)-weighted and T2-weighted imaging, T1 mapping, T2 mapping, transverse relaxation time (T2*) mapping, diffusion-weighted imaging, pseudocontinuous arterial spin labeling, non-contrast enhanced angiography, and phase-contrast measurement of renal artery flow. Glomerular filtration rate will be measured by [99mTc]Tc-diethylenetriaminepentaacetic acid (DTPA) clearance. A baseline allograft biopsy is taken during transplantation surgery, with protocol biopsies at 3, 12, and 24 months. Fibrosis is quantified using stereology. The primary outcome is the longitudinal association between the corticomedullary T1 difference and histologically determined renal fibrosis in KTRs across all 4 biopsy time points. Secondary analyses include longitudinal divergence of MRI and functional markers across cohorts, diagnostic performance for fibrosis, and predictive value for mGFR decline in KTRs and LKDs. Linear mixed models will be used to study longitudinal associations. Three additional MRI measures will be tested in a fixed sequence to control multiplicity. Receiver operating characteristic curve analysis will assess diagnostic performance.Results
The study was funded in October 2023. Recruitment for the multiparametric renal magnetic resonance imaging (MPRENAL) study commenced on October 29, 2024. As of March 2026, 42 participants were enrolled, and data collection is ongoing. Recruitment is anticipated to close in February 2027, with final study visits by March 2029. The primary results are expected to be published in 2030.Conclusions
Successful completion of this study is expected to provide robust histological validation of mpMRI and establish its utility as a noninvasive tool for monitoring renal health.
Related
- Virologic and Exploratory Immunologic Characterization of Relapsing Human Cytomegalovirus (HCMV) DNAemia in Solid Organ Transplant Recipients: A Prospective Observational Cohort Study
- Transfusion practices, thresholds, and complications in pediatric oncology patients: a single-center prospective longitudinal observational study
- Longitudinal Changes in Anxiety and Depression Following First Implantable Cardioverter-Defibrillator Implantation: A Prospective Observational Study
- Longitudinal psychosocial burden, quality of life, and digital supportive care preferences before and after CAR T-cell therapy: a prospective single-center observational study
- The frequency and timing of leukopenia and CMV infections in kidney transplant recipients in Finland – a retrospective observational study
BibTeX
@article{schjelderup2026multiparametric,
title = {{Multiparametric Magnetic Resonance Imaging in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls and Correlations With Markers of Renal Function, Fibrosis, and Aging (MPRENAL): Protocol for a Longitudinal Observational Study.}},
author = {Patrick Schjelderup and Steffen Ringgaard and Jens Brøndum Frøkjær and Jens Dam Jensen and Søren Krag and Jens Randel Nyengaard and Christoffer Laustsen and Niels Henrik Buus and Lars Jødal and Karin Skov and My Hanna Sofia Svensson},
journal = {JMIR research protocols},
year = {2026},
month = oct,
doi = {10.2196/97152},
url = {https://europepmc.org/article/MED/42954158},
note = {CC BY},
}
RIS
TY - JOUR
TI - Multiparametric Magnetic Resonance Imaging in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls and Correlations With Markers of Renal Function, Fibrosis, and Aging (MPRENAL): Protocol for a Longitudinal Observational Study.
AU - Patrick Schjelderup
AU - Steffen Ringgaard
AU - Jens Brøndum Frøkjær
AU - Jens Dam Jensen
AU - Søren Krag
AU - Jens Randel Nyengaard
AU - Christoffer Laustsen
AU - Niels Henrik Buus
AU - Lars Jødal
AU - Karin Skov
AU - My Hanna Sofia Svensson
PY - 2026
DA - 2026/10/01
JO - JMIR research protocols
DO - 10.2196/97152
UR - https://europepmc.org/article/MED/42954158
AB - Background Renal fibrosis is the final common pathway of chronic kidney disease progression and a critical histological predictor of renal function decline and allograft failure. Routine clinical monitoring with estimated glomerular filtration rate (eGFR) and albuminuria is insensitive to fibrosis development. Renal biopsy is invasive and subject to sampling bias, which limits repeated assessment, thus necessitating noninvasive imaging biomarkers. Multiparametric magnetic resonance imaging (mpMRI) characterizes renal structure and function noninvasively. Individual MRI measures have been associated with fibrosis and with declining renal function. However, longitudinal validation against histology and measured glomerular filtration rate (mGFR) remains limited.Objective This prospective longitudinal observational study aims to validate mpMRI against histological fibrosis assessed by kidney biopsy in kidney transplant recipients (KTRs), and compare the time-dependent trajectories of imaging and functional markers across living kidney donors (LKDs), KTRs, and healthy control (HC) cohorts.Methods The planned sample includes 32 LKDs, 32 KTRs, and 32 HCs. Up to 40 KTRs may be recruited to account for attrition. Baseline assessments are performed before transplantation for LKDs and KTRs, and at enrollment for HCs, with follow-up assessments at 3, 12, and 24 months. mpMRI is performed at 3 tesla (3 T). The MRI protocol includes structural longitudinal relaxation time (T1)-weighted and T2-weighted imaging, T1 mapping, T2 mapping, transverse relaxation time (T2*) mapping, diffusion-weighted imaging, pseudocontinuous arterial spin labeling, non-contrast enhanced angiography, and phase-contrast measurement of renal artery flow. Glomerular filtration rate will be measured by [99mTc]Tc-diethylenetriaminepentaacetic acid (DTPA) clearance. A baseline allograft biopsy is taken during transplantation surgery, with protocol biopsies at 3, 12, and 24 months. Fibrosis is quantified using stereology. The primary outcome is the longitudinal association between the corticomedullary T1 difference and histologically determined renal fibrosis in KTRs across all 4 biopsy time points. Secondary analyses include longitudinal divergence of MRI and functional markers across cohorts, diagnostic performance for fibrosis, and predictive value for mGFR decline in KTRs and LKDs. Linear mixed models will be used to study longitudinal associations. Three additional MRI measures will be tested in a fixed sequence to control multiplicity. Receiver operating characteristic curve analysis will assess diagnostic performance.Results The study was funded in October 2023. Recruitment for the multiparametric renal magnetic resonance imaging (MPRENAL) study commenced on October 29, 2024. As of March 2026, 42 participants were enrolled, and data collection is ongoing. Recruitment is anticipated to close in February 2027, with final study visits by March 2029. The primary results are expected to be published in 2030.Conclusions Successful completion of this study is expected to provide robust histological validation of mpMRI and establish its utility as a noninvasive tool for monitoring renal health.
SN - 1929-0748
ER -